Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Sees Significant Growth in Short Interest

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 10,281 shares, an increase of 165.0% from the June 30th total of 3,880 shares. Based on an average daily volume of 48,072 shares, the short-interest ratio is presently 0.2 days. Approximately 2.9% of the company’s shares are sold short.

Defiance Daily Target 2X Long LMND ETF Trading Up 6.1%

Shares of LMNX traded up $0.81 during trading hours on Monday, reaching $14.04. 68,271 shares of the company traded hands, compared to its average volume of 43,496. Defiance Daily Target 2X Long LMND ETF has a 12 month low of $10.17 and a 12 month high of $55.00. The company has a quick ratio of 6.08, a current ratio of 8.37 and a debt-to-equity ratio of 0.52. The company’s fifty day moving average price is $14.84 and its two-hundred day moving average price is $20.10. The company has a market capitalization of $5.34 million, a price-to-earnings ratio of 27.53 and a beta of 9.64.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.